[Treatment of oligometastatic or oligoprogression cancer].

[Treatment of oligometastatic or oligoprogression cancer].
Cancer Radiother. 2019 Sep 05;:
Authors: Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, Lemanski C, Riou O, Farcy-Jacquet MP, Azria D
Abstract
We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival, and to identify the place of SBRT in patient's pathway.
PMID: 31495737 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - September 4, 2019 Category: Cancer & Oncology Authors: Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, Lemanski C, Riou O, Farcy-Jacquet MP, Azria D Tags: Cancer Radiother Source Type: research